Literature DB >> 33054163

Antimicrobial Synergy of a Ribonuclease and a Peptide Secreted by Human Cells.

Chelcie H Eller, Ronald T Raines1.   

Abstract

LL-37 is a secretory peptide that has antimicrobial activity. Ribonuclease 1 (RNase 1) is a secretory enzyme that is not cytotoxic. We find that human LL-37 and human RNase 1 can act synergistically to kill Gram-negative bacterial cells. In the presence of nontoxic concentrations of LL-37, RNase 1 is toxic to Escherichia coli cells at picomolar levels. Using wild-type RNase 1 and an inactive variant labeled with a fluorophore, we observe the adherence of RNase 1 to E. coli cells and its cellular entry in the presence of LL-37. These data suggest a natural means of modulating the human microbiome via the cooperation of an endogenous peptide (37 residues) and small enzyme (128 residues).

Entities:  

Keywords:  antimicrobial peptide; cathelicidin; microbiome; ribonuclease 1; synergism

Mesh:

Substances:

Year:  2020        PMID: 33054163      PMCID: PMC7669604          DOI: 10.1021/acsinfecdis.0c00594

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  53 in total

Review 1.  Antimicrobial peptides: Application informed by evolution.

Authors:  Brian P Lazzaro; Michael Zasloff; Jens Rolff
Journal:  Science       Date:  2020-05-01       Impact factor: 47.728

Review 2.  New directions in inflammation and immunity: the multi-functional role of the extracellular RNA/RNase system.

Authors:  Elisabeth Deindl; Silvia Fischer; Klaus T Preissner
Journal:  Indian J Biochem Biophys       Date:  2009-12       Impact factor: 1.918

3.  Rational design and evaluation of mammalian ribonuclease cytotoxins.

Authors:  Jo E Lomax; Chelcie H Eller; Ronald T Raines
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 4.  The human skin microbiome.

Authors:  Allyson L Byrd; Yasmine Belkaid; Julia A Segre
Journal:  Nat Rev Microbiol       Date:  2018-01-15       Impact factor: 60.633

5.  Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.

Authors:  Guangshun Wang; Melissa Elliott; Anna L Cogen; Edward L Ezell; Richard L Gallo; Robert E W Hancock
Journal:  Biochemistry       Date:  2012-01-06       Impact factor: 3.162

Review 6.  Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.

Authors:  Jiarui Li; Pablo Fernández-Millán; Ester Boix
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

Review 7.  Structural determinants of the eosinophil cationic protein antimicrobial activity.

Authors:  Ester Boix; Vivian A Salazar; Marc Torrent; David Pulido; M Victòria Nogués; Mohammed Moussaoui
Journal:  Biol Chem       Date:  2012-08       Impact factor: 3.915

Review 8.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

Authors:  Margit Mahlapuu; Joakim Håkansson; Lovisa Ringstad; Camilla Björn
Journal:  Front Cell Infect Microbiol       Date:  2016-12-27       Impact factor: 5.293

Review 9.  The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily.

Authors:  Laura Schwartz; Ariel Cohen; Jason Thomas; John David Spencer
Journal:  Vaccines (Basel)       Date:  2018-11-20

Review 10.  Ribonucleases as antiviral agents.

Authors:  O N Ilinskaya; R Shah Mahmud
Journal:  Mol Biol       Date:  2014-10-11       Impact factor: 1.374

View more
  5 in total

1.  Semisynthesis of Human Ribonuclease-S.

Authors:  Jessica Sayers; Evans C Wralstad; Ronald T Raines
Journal:  Bioconjug Chem       Date:  2020-12-09       Impact factor: 4.774

Review 2.  Tackling antimicrobial stewardship through synergy and antimicrobial peptides.

Authors:  Jenna M Greve; James A Cowan
Journal:  RSC Med Chem       Date:  2022-04-04

Review 3.  Emerging biological functions of ribonuclease 1 and angiogenin.

Authors:  Emily R Garnett; Ronald T Raines
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-12-09       Impact factor: 8.697

4.  Exploring the RNase A scaffold to combine catalytic and antimicrobial activities. Structural characterization of RNase 3/1 chimeras.

Authors:  Pablo Fernández-Millán; Sergi Vázquez-Monteagudo; Ester Boix; Guillem Prats-Ejarque
Journal:  Front Mol Biosci       Date:  2022-09-14

Review 5.  Nanozybiotics: Nanozyme-Based Antibacterials against Bacterial Resistance.

Authors:  Caiyu Zhou; Qian Wang; Jing Jiang; Lizeng Gao
Journal:  Antibiotics (Basel)       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.